Skip to main content
SpringerLink
Log in

Axitinib

Posterior reversible encephalopathy syndrome: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Prasad A, et al. A Rare Case of Posterior Reversible Encephalopathy Syndrome (PRES) Associated with Axitinib in Renal Cell Cancer. Annals of Neurology 92 (Suppl. 29): S175 abstr. S264, Oct 2022. Available from: URL: http://doi.org/10.1002/ana.26484 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Axitinib. Reactions Weekly 1935, 101 (2022). https://doi.org/10.1007/s40278-022-28896-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28896-z

Search

Navigation